According to the abovementioned facts, and to obtain novel multi-target anti-cancer drugs, a new series of thiazolidinediones-sulfonylthiourea hybrid was synthesized as potent PPARγ agonists and VEGFR-2 inhibitors. Here, KDR is linked to cancer.